References
- Ginwala R, Mctish E, Raman C, et al. Apigenin, a natural flavonoid, attenuates EAE severity through the modulation of dendritic cell and other immune cell functions. J Neuroimmune Pharmacol 2016;11:36–47.
- Hashemi M, Nouri LM, Entezari M, et al. Anti-mutagenic and pro-apoptotic effects of apigenin on human chronic lymphocytic leukemia cells. Acta Med Iran 2010;48:283–8.
- Karamese M, Erol HS, Albayrak M, et al. Anti-oxidant and anti-inflammatory effects of apigenin in a rat model of sepsis: an immunological, biochemical, and histopathological study. Immunopharmacol Immunotoxicol 2016;38:228–37.
- Coombs MR, Harrison ME, Hoskin DW. Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells. Cancer Lett 2016;380:424–33.
- Kim B, Jung N, Lee S, et al. Apigenin inhibits cancer stem cell-like phenotypes in human glioblastoma cells via suppression of c-Met signaling. Phytother Res 2016;30:1833–40.
- Lim W, Park S, Bazer FW, Song G. Apigenin reduces survival of choriocarcinoma cells by inducing apoptosis via the PI3K/AKT and ERK1/2 MAPK pathways. J Cell Physiol 2016;231:2690–9.
- Tseng TH, Chien MH, Lin WL, et al. Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21WAF1/CIP1 expression. Environ Toxicol 2017;32:434–44.
- Cardenas H, Arango D, Nicholas C, et al. Dietary apigenin exerts immune-regulatory activity in vivo by reducing NF-κB activity, halting leukocyte infiltration and restoring normal metabolic function. Int J Mol Sci 2016;17:323–40.
- Shukla S, Kanwal R, Shankar E, et al. Apigenin blocks IKKα activation and suppresses prostate cancer progression. Oncotarget 2015;6:31216–32.
- Zhang H, Yang X, Zhao L, et al. In vitro and in vivo study of Baicalin-loaded mixed micelles for oral delivery. Drug Deliv 2012;23:1933–9.
- Joshi G, Kumar A, Sawant K. Bioavailability enhancement, Caco-2 cells uptake and intestinal transport of orally administered lopinavir-loaded PLGA nanoparticles. Drug Deliv 2016;23:3492–504.
- Ullah S, Shah MR, Shoaib M, et al. Development of a biocompatible creatinine-based niosomal delivery system for enhanced oral bioavailability of clarithromycin. Drug Deliv 2016;23:3480–91.
- Yang L, Xin J, Zhang Z, et al. TPGS-modified liposomes for the delivery of ginsenoside compound K against non-small cell lung cancer: formulation design and its evaluation in vitro and in vivo. J Pharm Pharmacol 2016;68:1109–18.
- Alvarez-Rivera F, Fernandez-Villanueva D, Concheiro A, et al. alpha-Lipoic acid in soluplus® polymeric nanomicelles for ocular treatment of diabetes-associated corneal diseases. J Pharm Sci 2016;105:2855–63.
- Lee SY, Lee JJ, Park JH, et al. Electrosprayed nanocomposites based on hyaluronic acid derivative and Soluplus for tumor-targeted drug delivery. Colloids Surf B Biointerfaces 2016;145:267–74.
- Yoon DY, Kim JC. In vivo residence duration of human growth hormone loaded in nanogels comprising cinnamoyl alginate, cinnamoyl Pluronic F127 and cinnamoyl poly(ethylene glycol). Int J Pharm 2016;509:229–36.
- Dehghan KP, Saadat E, Ravar F, et al. Pluronic F127 polymeric micelles for co-delivery of paclitaxel and lapatinib against metastatic breast cancer: preparation, optimization and in vitro evaluation. Pharm Dev Technol 2015;20:1–9.
- Li X, Yu Y, Ji Q, et al. Targeted delivery of anticancer drugs by aptamer AS1411 mediated Pluronic F127/cyclodextrin-linked polymer composite micelles. Nanomedicine 2015;11:175–84.
- Hou J, Wang J, Sun E, et al. Preparation and evaluation of icariside II-loaded binary mixed micelles using Solutol HS15 and Pluronic F127 as carriers. Drug Deliv 2016;23:3248–56.
- Feng Y, Sun C, Yuan Y, et al. Enhanced oral bioavailability and in vivo antioxidant activity of chlorogenic acid via liposomal formulation. Int J Pharm 2016;501:342–9.
- Naseem B, Shah SW, Hasan A, et al. Interaction of flavonoids, the naturally occurring antioxidants with different media: a UV-visible spectroscopic study. Spectrochim Acta A Mol Biomol Spectrosc 2010;75:1341–6.
- Glowacki R, Furmaniak P, Kubalczyk P, et al. Determination of total apigenin in herbs by micellar electrokinetic chromatography with UV detection. J Anal Methods Chem 2016;2016:3827832.
- Bernabeu E, Gonzalez L, Cagel M, et al. Novel Soluplus®-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines. Colloids Surf B Biointerfaces 2016;140:403–11.
- Wang CF, Yuan JR, Qin D, et al. Protection of tauroursodeoxycholic acid on high glucose-induced human retinal microvascular endothelial cells dysfunction and streptozotocin-induced diabetic retinopathy rats. J Ethnopharmacol 2016;185:162–70.
- Munyendo WL, Zhenhai Z, Abbad S, et al. Micelles of TPGS modified apigenin phospholipid complex for oral administration: preparation, in vitro and in vivo evaluation. J Biomed Nanotechnol 2013;9:2034–47.
- Han X, Wang Z, Wang M, et al. Liver-targeting self-assembled hyaluronic acid-glycyrrhetinic acid micelles enhance hepato-protective effect of silybin after oral administration. Drug Deliv 2016;23:1818–29.
- Ni J, Tian F, Dahmani FZ, et al. Curcumin-carboxymethyl chitosan (CNC) conjugate and CNC/LHR mixed polymeric micelles as new approaches to improve the oral absorption of P-gp substrate drugs. Drug Deliv 2016;23:3424–35.
- Zhang J, Liu D, Huang Y, et al. Biopharmaceutics classification and intestinal absorption study of apigenin. Int J Pharm 2012;436:311–17.